Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V G Radchenko

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Tsitologiia|August 23, 2000
[Metabolic heterogeneity of glycogen in hepatocytes of patients with liver cirrhosis]M V Kudriavtseva, N N Bezborodkina, V G Radchenko, et al.
Terapevticheskii Arkhiv|February 24, 2011
[Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)]T V Sologub, M G Romantsev, A A Shul'diakov, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|January 29, 2016
[AUTOIMMUNE LIVER DISEASES: CLINICAL FEATURES, DIAGNOSIS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015]E V Golovanova, L B Lazebnik, Yu V Konev, et al.
Klinicheskaia Meditsina|October 6, 2010
[Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver]T V Sologub, M G Romantsov, A A Shul'diakov, et al.
Vestnik Rentgenologii I Radiologii|March 14, 2000
[Possibilities of the liver MRI in complex diagnosis of primary hemochromatosis and in evaluation of the treatment effectiveness]O A Smirnov, N A Mitrofanov, V G Radchenko, et al.
Arkhiv Patologii|October 2, 2003
[Liver pathology in patients with primary hemochromatosis--homozygous carriers of C282Y mutation ]O A Smirnov, O V Shneĭder, V G Radchenko, et al.
Klinicheskaia Meditsina|April 8, 2010
[Hepatoprotective activity of remaxol in patients with chronic hepatic disorders]T V Sologub, L G Goriacheva, D S Sukhanov, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|September 22, 2015
[GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CELIAC DISEASE]L B Lazebnik, Ye I Tkachenko, L S Oreshko, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|February 8, 2014
[Standards for diagnosis and treatment of acid and Helicobacter pylori-associated diseases]L B Lazebnik, E I Tkachenko, R A Abdulkhakov, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|January 29, 2016
[NONALCOHOLIC FATTY LIVER DISEASE: DIAGNOSTIC, SYMPTOMS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015]L B Lazebnik, V G Radchenko, E V Golovanova, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Tsitologiia|August 23, 2000
[Metabolic heterogeneity of glycogen in hepatocytes of patients with liver cirrhosis]M V Kudriavtseva, N N Bezborodkina, V G Radchenko, et al.
Terapevticheskii Arkhiv|February 24, 2011
[Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)]T V Sologub, M G Romantsev, A A Shul'diakov, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|January 29, 2016
[AUTOIMMUNE LIVER DISEASES: CLINICAL FEATURES, DIAGNOSIS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015]E V Golovanova, L B Lazebnik, Yu V Konev, et al.
Klinicheskaia Meditsina|October 6, 2010
[Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver]T V Sologub, M G Romantsov, A A Shul'diakov, et al.
Vestnik Rentgenologii I Radiologii|March 14, 2000
[Possibilities of the liver MRI in complex diagnosis of primary hemochromatosis and in evaluation of the treatment effectiveness]O A Smirnov, N A Mitrofanov, V G Radchenko, et al.
Arkhiv Patologii|October 2, 2003
[Liver pathology in patients with primary hemochromatosis--homozygous carriers of C282Y mutation ]O A Smirnov, O V Shneĭder, V G Radchenko, et al.
Klinicheskaia Meditsina|April 8, 2010
[Hepatoprotective activity of remaxol in patients with chronic hepatic disorders]T V Sologub, L G Goriacheva, D S Sukhanov, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|September 22, 2015
[GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CELIAC DISEASE]L B Lazebnik, Ye I Tkachenko, L S Oreshko, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|February 8, 2014
[Standards for diagnosis and treatment of acid and Helicobacter pylori-associated diseases]L B Lazebnik, E I Tkachenko, R A Abdulkhakov, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|January 29, 2016
[NONALCOHOLIC FATTY LIVER DISEASE: DIAGNOSTIC, SYMPTOMS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015]L B Lazebnik, V G Radchenko, E V Golovanova, et al.
Pageof 4